JPRN-jRCT1080224910招募中Unknown
VANFLYTA Tablet Post-marketing Surveillance Study
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •All patients who start receiving VANFLYTA Tablet during the registration period.
排除标准
- •Patients with a previous history of hypersensitivity to the ingredients of VANFLYTA.
研究者
相似试验
招募中
Unknown
Ezharmia Tablet Post-marketing SurveillanceRelapsed or refractory Adult T-cell leukemia/lymphoma (ATL)JPRN-jRCT2031220503Matsuoka Yomei150
招募中
Unknown
All case study of Lenvima Capsulenresectable thyroid cancerJPRN-jRCT1080222856Eisai Co., Ltd.400
进行中（未招募）
4 期
A post-marketing surveillance study to evaluate the safety and immunological response of typhoid conjugate vaccine in healthy subjectsCTRI/2021/11/037996Cadila Healthcare Limited
已完成
不适用
Safety and efficacy of a fixed dose combination of cefepime and amikaciosocomial pneumonia, febrile neutropenia, other bacterial infectionsInfections and InfestationsInfectionsISRCTN61799591Venus Remedies Limited (India)315
已完成
4 期
A post-marketing study of the marketed product Maxtra® PDS syrup for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031188Zuventus Healthcare Limited200